99 related articles for article (PubMed ID: 25005449)
21. Anti-glomerular basement membrane glomerulonephritis complicated by thrombocytopenia.
Miki T; Akimoto T; Sugase T; Numata A; Otani N; Iwazu Y; Takeshima E; Morishita Y; Muto S; Kusano E
Intern Med; 2012; 51(24):3395-9. PubMed ID: 23257527
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA.
Gu L; Chen H; Tuo J; Gao X; Chen L
Exp Eye Res; 2010 Sep; 91(3):433-9. PubMed ID: 20599960
[TBL] [Abstract][Full Text] [Related]
23. The importance of cell-mediated immunity in the course and severity of autoimmune anti-glomerular basement membrane disease in mice.
Hopfer H; Maron R; Butzmann U; Helmchen U; Weiner HL; Kalluri R
FASEB J; 2003 May; 17(8):860-8. PubMed ID: 12724345
[TBL] [Abstract][Full Text] [Related]
24. Anti-glomerular basement membrane glomerulonephritis and thrombotic microangiopathy in first degree relatives: a case report.
Idorn T; Schejbel L; Rydahl C; Heaf JG; Jølvig KR; Bergstrøm M; Garred P; Kamper AL
BMC Nephrol; 2012 Jul; 13():64. PubMed ID: 22834933
[TBL] [Abstract][Full Text] [Related]
25. Superoxide dismutase mimetic drug tempol aggravates anti-GBM antibody-induced glomerulonephritis in mice.
Lu H; Zhen J; Wu T; Peng A; Ye T; Wang T; Yu X; Vaziri ND; Mohan C; Zhou XJ
Am J Physiol Renal Physiol; 2010 Aug; 299(2):F445-52. PubMed ID: 20504883
[TBL] [Abstract][Full Text] [Related]
26. IL-18 translational inhibition restricts IFN-gamma expression in crescentic glomerulonephritis.
Garcia GE; Xia Y; Ku G; Johnson RJ; Wilson CB; Feng L
Kidney Int; 2003 Jul; 64(1):160-9. PubMed ID: 12787406
[TBL] [Abstract][Full Text] [Related]
27. ANG II receptor blockade enhances anti-inflammatory macrophages in anti-glomerular basement membrane glomerulonephritis.
Aki K; Shimizu A; Masuda Y; Kuwahara N; Arai T; Ishikawa A; Fujita E; Mii A; Natori Y; Fukunaga Y; Fukuda Y
Am J Physiol Renal Physiol; 2010 Apr; 298(4):F870-82. PubMed ID: 20071465
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of CXCL16 attenuates inflammatory and progressive phases of anti-glomerular basement membrane antibody-associated glomerulonephritis.
Garcia GE; Truong LD; Li P; Zhang P; Johnson RJ; Wilson CB; Feng L
Am J Pathol; 2007 May; 170(5):1485-96. PubMed ID: 17456756
[TBL] [Abstract][Full Text] [Related]
29. Suppression of experimental crescentic glomerulonephritis by interleukin-10 gene transfer.
El-Shemi AG; Fujinaka H; Matsuki A; Kamiie J; Kovalenko P; Qu Z; Bilim V; Nishimoto G; Yaoita E; Yoshida Y; Anegon I; Yamamoto T
Kidney Int; 2004 Apr; 65(4):1280-9. PubMed ID: 15086467
[TBL] [Abstract][Full Text] [Related]
30. VEGF regulates local inhibitory complement proteins in the eye and kidney.
Keir LS; Firth R; Aponik L; Feitelberg D; Sakimoto S; Aguilar E; Welsh GI; Richards A; Usui Y; Satchell SC; Kuzmuk V; Coward RJ; Goult J; Bull KR; Sharma R; Bharti K; Westenskow PD; Michael IP; Saleem MA; Friedlander M
J Clin Invest; 2017 Jan; 127(1):199-214. PubMed ID: 27918307
[TBL] [Abstract][Full Text] [Related]
31. Case of anti-glomerular basement membrane antibody-induced glomerulonephritis with cytomegalovirus-induced thrombotic microangiopathy.
Shiraishi N; Kitamura K; Hayata M; Ogata T; Adachi M; Kajiwara K; Ikeda H; Miyoshi T; Tomita K
Intern Med J; 2012 Mar; 42(3):e7-e11. PubMed ID: 22432999
[TBL] [Abstract][Full Text] [Related]
32. The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease.
Reynolds J; Moss J; Duda MA; Smith J; Karkar AM; Macherla V; Shore I; Evans DJ; Woodrow DF; Pusey CD
J Pathol; 2003 May; 200(1):118-29. PubMed ID: 12692850
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of HO-1 mediated attenuation of renal immune injury: a gene profiling study.
Duann P; Lianos EA
Transl Res; 2011 Oct; 158(4):249-61. PubMed ID: 21925121
[TBL] [Abstract][Full Text] [Related]
34. Characteristic morphological changes in anti-VEGF therapy-induced glomerular microangiopathy.
Pfister F; Amann K; Daniel C; Klewer M; Büttner A; Büttner-Herold M
Histopathology; 2018 Dec; 73(6):990-1001. PubMed ID: 30014486
[TBL] [Abstract][Full Text] [Related]
35. Thrombotic microangiopathy in patients with diabetic nephropathy is associated with low VEGF expression and end-stage renal disease
.
Hernández-Arteaga K; Soto-Abraham V; Pérez-Navarro M; de León-Garza B; Rodríguez-Matías A; Olvera-Soto MG; Valdez-Ortiz R
Clin Nephrol; 2018 Jun; 89(6):429-437. PubMed ID: 29249229
[TBL] [Abstract][Full Text] [Related]
36. [A clinical and pathological analysis of 41 patients with anti-glomerular basement membrane antibody related diseases].
Zhao M; Ding J; Liu Y; Zou W; Wang H
Zhonghua Nei Ke Za Zhi; 2001 May; 40(5):316-20. PubMed ID: 11798594
[TBL] [Abstract][Full Text] [Related]
37. Complement-Mediated Thrombotic Microangiopathy in a Patient With Antiphospholipid Syndrome and Anti-glomerular Basement Membrane Antibodies.
Gallant TL; Zheng E; Hobbs AM; Becka AJ; Bertsch RA
Cureus; 2023 Jul; 15(7):e42410. PubMed ID: 37637585
[TBL] [Abstract][Full Text] [Related]
38. Resistance of Fc receptor- deficient mice to fatal glomerulonephritis.
Park SY; Ueda S; Ohno H; Hamano Y; Tanaka M; Shiratori T; Yamazaki T; Arase H; Arase N; Karasawa A; Sato S; Ledermann B; Kondo Y; Okumura K; Ra C; Saito T
J Clin Invest; 1998 Sep; 102(6):1229-38. PubMed ID: 9739057
[TBL] [Abstract][Full Text] [Related]
39. P-selectin deficiency exacerbates experimental glomerulonephritis: a protective role for endothelial P-selectin in inflammation.
Rosenkranz AR; Mendrick DL; Cotran RS; Mayadas TN
J Clin Invest; 1999 Mar; 103(5):649-59. PubMed ID: 10074481
[TBL] [Abstract][Full Text] [Related]
40. CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice.
Wolf D; Hochegger K; Wolf AM; Rumpold HF; Gastl G; Tilg H; Mayer G; Gunsilius E; Rosenkranz AR
J Am Soc Nephrol; 2005 May; 16(5):1360-70. PubMed ID: 15788479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
